Found: 21
Select item for more details and to access through your institution.
YAP-1 Promotes Tregs Differentiation in Hepatocellular Carcinoma by Enhancing TGFBR2 Transcription.
- Published in:
- Cellular Physiology & Biochemistry (Karger AG), 2017, v. 41, n. 3, p. 1189, doi. 10.1159/000464380
- By:
- Publication type:
- Article
C/EBP homologous protein (CHOP) contributes to hepatocyte death via the promotion of ERO1ɑ signalling in acute liver failure.
- Published in:
- Biochemical Journal, 2015, v. 466, n. 2, p. 369, doi. 10.1042/BJ20140412
- By:
- Publication type:
- Article
Hyperglycemia-triggered ATF6-CHOP pathway aggravates acute inflammatory liver injury by β-catenin signaling.
- Published in:
- Cell Death Discovery, 2022, v. 8, n. 1, p. 1, doi. 10.1038/s41420-022-00910-z
- By:
- Publication type:
- Article
Over-expression of Toll-like receptors and their ligands in small-for-size graft.
- Published in:
- Hepatology Research, 2010, v. 40, n. 3, p. 318, doi. 10.1111/j.1872-034X.2009.00603.x
- By:
- Publication type:
- Article
Lipopolysaccharide Preconditioning Protects Hepatocytes from Ischemia/Reperfusion Injury (IRI) through Inhibiting ATF4-CHOP Pathway in Mice.
- Published in:
- PLoS ONE, 2013, v. 8, n. 6, p. 1, doi. 10.1371/journal.pone.0065568
- By:
- Publication type:
- Article
BUB1B promotes hepatocellular carcinoma progression via activation of the mTORC1 signaling pathway.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 21, p. 8159, doi. 10.1002/cam4.3411
- By:
- Publication type:
- Article
miRNA‐130b‐5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression.
- Published in:
- Journal of Cellular & Molecular Medicine, 2021, v. 25, n. 15, p. 7381, doi. 10.1111/jcmm.16766
- By:
- Publication type:
- Article
Inhibition of Glycogen Synthase Kinase 3β Increases the Proportion and Suppressive Function of CD19<sup>+</sup>CD24<sup>hi</sup>CD27<sup>+</sup> Breg Cells.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. N.PAG, doi. 10.3389/fimmu.2020.603288
- By:
- Publication type:
- Article
Leveraging Patient-Derived Organoids for Personalized Liver Cancer Treatment.
- Published in:
- International Journal of Biological Sciences, 2024, v. 20, n. 13, p. 5363, doi. 10.7150/ijbs.96317
- By:
- Publication type:
- Article
Retraction Note: miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 3, p. 1, doi. 10.1038/s41419-023-05765-5
- By:
- Publication type:
- Article
Retraction Note to: miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB.
- Published in:
- Cell Death & Disease, 2023, v. 14, n. 2, p. 1, doi. 10.1038/s41419-023-05654-x
- By:
- Publication type:
- Article
Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 11, p. 1, doi. 10.1038/s41419-018-1134-4
- By:
- Publication type:
- Article
miR-665 promotes hepatocellular carcinoma cell migration, invasion, and proliferation by decreasing Hippo signaling through targeting PTPRB.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 10, p. 1, doi. 10.1038/s41419-018-0978-y
- By:
- Publication type:
- Article
miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
- Published in:
- Cell Death & Disease, 2017, v. 8, n. 8, p. e2999, doi. 10.1038/cddis.2017.356
- By:
- Publication type:
- Article
The oncogene Mct-1 promotes progression of hepatocellular carcinoma via enhancement of Yap-mediated cell proliferation.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00413-3
- By:
- Publication type:
- Article
Dysregulation of miR-23b-5p promotes cell proliferation via targeting FOXM1 in hepatocellular carcinoma.
- Published in:
- Cell Death Discovery, 2021, v. 7, n. 1, p. 1, doi. 10.1038/s41420-021-00440-0
- By:
- Publication type:
- Article
Corrigendum to: Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex.
- Published in:
- International Immunology, 2022, v. 34, n. 1, p. 53, doi. 10.1093/intimm/dxab105
- By:
- Publication type:
- Article
Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex.
- Published in:
- International Immunology, 2020, v. 32, n. 5, p. 321, doi. 10.1093/intimm/dxaa002
- By:
- Publication type:
- Article
Safety and Efficacy of Sintilimab and Anlotinib as First Line Treatment for Advanced Hepatocellular Carcinoma (KEEP-G04): A Single-Arm Phase 2 Study.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.909035
- By:
- Publication type:
- Article
Aging aggravated liver ischemia and reperfusion injury by promoting STING‐mediated NLRP3 activation in macrophages.
- Published in:
- Aging Cell, 2020, v. 19, n. 8, p. 1, doi. 10.1111/acel.13186
- By:
- Publication type:
- Article
Circular RNA circGSK3B Promotes Cell Proliferation, Migration, and Invasion by Sponging miR-1265 and Regulating CAB39 Expression in Hepatocellular Carcinoma.
- Published in:
- Frontiers in Oncology, 2020, v. 11, p. N.PAG, doi. 10.3389/fonc.2020.598256
- By:
- Publication type:
- Article